| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.0094 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |